Compare Bundamedik Tbk (BMHS) vs Citra Nusantara Gemilang Tbk. (CGAS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bundamedik Tbk vs Citra Nusantara Gemilang Tbk. — how do they compare? Bundamedik Tbk trades at Rp189 (market cap 1.62T, 35.6K 24h volume), while Citra Nusantara Gemilang Tbk. trades at Rp150 (market cap 263.95B, 573.9K 24h volume). The key difference: Bundamedik Tbk is far larger — about 6.1× Citra Nusantara Gemilang Tbk.'s market cap, and Citra Nusantara Gemilang Tbk. is more actively traded (573.9K versus 35.6K). Which is the better fit depends on your goals.
| BMHS | CGAS | |
|---|---|---|
Market Cap | 1.62T | 263.95B |
Volume | 35.6K | 573.9K |
Lot | 356 | 5.74K |
Turnover | 6.75M | 86.38M |
Average Price | 189.63 | 150.51 |
Value | 6.75M | 86.38M |
Indicative Equilibrium Price | 190 | 150 |
Indicative Equilibrium Volume | 52 | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bundamedik Tbk
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →About Citra Nusantara Gemilang Tbk.
PT Citra Nusantara Gemilang Tbk (the “Company”), was established based on Notarial Deed No. 22, dated December 21, 2005 of Edi Priyono, S.H.. The Company's parent entity is PT Petro Asia Energy
Read more on CGAS →
